ISAPP Comments on CBER Proposal on INDs

May 28, 2015. ISAPP filed comments on an FDA-CBER proposal regarding CMC information required for INDs on probiotic research (Federal Register Notice).  ISAPP welcomes this proposal by CBER that the label on a commercially available product would be adequate to satisfy CMC information.  ISAPP comments.